| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Biomedical Research, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113 [Z. C., M. N., T. M., T. T.], and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 1-37-1, Kami-Ikebukuro, Toshima-ku, Tokyo 170 [T. T.], Japan
We have previously reported that actin cleavage activity (ACA) by interleukin 1ß-converting enzyme (ICE) family protease was elevated during anticancer drug-induced apoptosis in human leukemia U937 cells. In this study, the involvement of ACA in the drug-induced apoptosis in solid tumor cells was investigated. Human ovarian carcinoma OVCAR-3 cells undergo apoptotic cell death when cells are treated with chemotherapeutic agents such as cisplatin and etoposide. The induction of the actin cleavage activity accompanied the development of apoptosis. ICE/ced-3 family protease inhibitors such as Z-VAD-CH2DCB and Z-EVD-CH2DCB at 100 µg/ml prevented both the emergence of ACA and the morphological change, characteristics of apoptosis, in cisplatin-treated OVCAR-3 cells. The ACA in apoptotic OVCAR-3 cell lysate was greatly adsorbed by antibody against CPP-32, an ICE family protease. Furthermore, the immunoprecipitated CPP-32 from OVCAR-3 lysate could cleave actin to generate a 15-kDa fragment, as did the apoptotic OVCAR-3 cell lysate, indicating that CPP-32 is a major protease responsible for the ACA. The activation of CPP-32 in the drug-treated cell lysate was verified with Western blot analysis. Our present results indicate that CPP-32, an actin cleavage ICE/ced-3 family protease, could be a common mediator involved in the process of chemotherapy-induced apoptosis of cancer cells.
1 This study was supported in part by grants from the Ministry of Education, Science and Culture, Japan and the Special Coordination Fund of the Science and Technology Agency, Japan.
2 To whom requests for reprints should be addressed.
Received 7/18/96. Accepted 9/19/96.
This article has been cited by other articles:
![]() |
K. Stahnke, S. Fulda, C. Friesen, G. Strau{beta}, and K.-M. Debatin Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy Blood, November 15, 2001; 98(10): 3066 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biroccio, B. Benassi, S. Amodei, C. Gabellini, D. Del Bufalo, and G. Zupi C-Myc Down-Regulation Increases Susceptibility to Cisplatin through Reactive Oxygen Species-Mediated Apoptosis in M14 Human Melanoma Cells Mol. Pharmacol., July 1, 2001; 60(1): 174 - 182. [Abstract] [Full Text] |
||||
![]() |
S. R. White, P. Williams, K. R. Wojcik, S. Sun, P. S. Hiemstra, K. F. Rabe, and D. R. Dorscheid Initiation of Apoptosis by Actin Cytoskeletal Derangement in Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 282 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Asselin, G. B. Mills, and B. K. Tsang XIAP Regulates Akt Activity and Caspase-3-dependent Cleavage during Cisplatin-induced Apoptosis in Human Ovarian Epithelial Cancer Cells Cancer Res., March 1, 2001; 61(5): 1862 - 1868. [Abstract] [Full Text] |
||||
![]() |
H. Sasaki, Y. Sheng, F. Kotsuji, and B. K. Tsang Down-Regulation of X-linked Inhibitor of Apoptosis Protein Induces Apoptosis in Chemoresistant Human Ovarian Cancer Cells Cancer Res., October 1, 2000; 60(20): 5659 - 5666. [Abstract] [Full Text] |
||||
![]() |
A. Nakashio, N. Fujita, S. Rokudai, S. Sato, and T. Tsuruo Prevention of Phosphatidylinositol 3'-Kinase-Akt Survival Signaling Pathway during Topotecan-induced Apoptosis Cancer Res., September 1, 2000; 60(18): 5303 - 5309. [Abstract] [Full Text] |
||||
![]() |
W Bursch, K Hochegger, L Torok, B Marian, A Ellinger, and R. Hermann Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments J. Cell Sci., January 4, 2000; 113(7): 1189 - 1198. [Abstract] [PDF] |
||||
![]() |
S. Wesselborg, I. H. Engels, E. Rossmann, M. Los, and K. Schulze-Osthoff Anticancer Drugs Induce Caspase-8/FLICE Activation and Apoptosis in the Absence of CD95 Receptor/Ligand Interaction Blood, May 1, 1999; 93(9): 3053 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Posey and B. E. Bierer Actin Stabilization by Jasplakinolide Enhances Apoptosis Induced by Cytokine Deprivation J. Biol. Chem., February 12, 1999; 274(7): 4259 - 4265. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. JANMEY The Cytoskeleton and Cell Signaling: Component Localization and Mechanical Coupling Physiol Rev, July 1, 1998; 78(3): 763 - 781. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |